SK3 Group Inc. (OTCPK:SKTO) signed a definitive agreement to acquire Berkeley Bio-Organic Research Laboratories from Dave Hoye, Mary Ann Harrel, D. Allen Gray and Charles Apel for $0.87 million in stock on April 28, 2013. As consideration, SK3 will issue 20 million shares. Each of the shareholders will receive 5 million shares as consideration.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 1.24K | |
+6.13% | 7.41B | |
-32.64% | 3.24B | |
+11.38% | 1.75B | |
-9.32% | 1.08B | |
+31.69% | 907M | |
-7.64% | 714M | |
-3.60% | 606M | |
-8.30% | 539M | |
-22.29% | 515M |
- Stock Market
- Equities
- SKTO Stock
- News SK3 Group, Inc.
- SK3 Group Inc. signed a definitive agreement to acquire Berkeley Bio-Organic Research Laboratories from Dave Hoye, Mary Ann Harrel, D. Allen Gray and Charles Apel for $0.87 million.